Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 26-May 2015. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 139001000087111 | VariZIG 125 international units powder and diluent for solution for injection Cangene Corporation (real clinical drug) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 96711000087116 | VariZIG 125 international units powder and diluent for solution for injection Cangene Corporation | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 96721000087112 | VarIg VariZIG Cang | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 97731000087111 | VarIg VariZIG Cang | fr | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway French module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| VariZIG 125 international units powder and diluent for solution for injection Cangene Corporation (real clinical drug) | Plays role | Passive immunity stimulant therapeutic role | true | Inferred relationship | Some | ||
| VariZIG 125 international units powder and diluent for solution for injection Cangene Corporation (real clinical drug) | Has basis of strength substance (attribute) | Varicella immunoglobulin | true | Inferred relationship | Some | 1 | |
| VariZIG 125 international units powder and diluent for solution for injection Cangene Corporation (real clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| VariZIG 125 international units powder and diluent for solution for injection Cangene Corporation (real clinical drug) | Has supplier | Cangene Corporation (supplier) | true | Inferred relationship | Some | ||
| VariZIG 125 international units powder and diluent for solution for injection Cangene Corporation (real clinical drug) | Has presentation strength numerator unit | Unit | true | Inferred relationship | Some | 1 | |
| VariZIG 125 international units powder and diluent for solution for injection Cangene Corporation (real clinical drug) | Has presentation strength denominator unit (attribute) | Vial (unit of presentation) | true | Inferred relationship | Some | 1 | |
| VariZIG 125 international units powder and diluent for solution for injection Cangene Corporation (real clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
| VariZIG 125 international units powder and diluent for solution for injection Cangene Corporation (real clinical drug) | Has presentation strength numerator value (attribute) | 125 (qualifier value) | false | Inferred relationship | Some | 1 | |
| VariZIG 125 international units powder and diluent for solution for injection Cangene Corporation (real clinical drug) | a une forme pharmaceutique (attribut) | Powder for solution for injection | true | Inferred relationship | Some | ||
| VariZIG 125 international units powder and diluent for solution for injection Cangene Corporation (real clinical drug) | Has unit of presentation | Vial (unit of presentation) | true | Inferred relationship | Some | ||
| VariZIG 125 international units powder and diluent for solution for injection Cangene Corporation (real clinical drug) | est un(e) (attribut) | Varicella-zoster virus antibody only product in parenteral dose form | true | Inferred relationship | Some | ||
| VariZIG 125 international units powder and diluent for solution for injection Cangene Corporation (real clinical drug) | Has precise active ingredient | Varicella immunoglobulin | true | Inferred relationship | Some | 1 | |
| VariZIG 125 international units powder and diluent for solution for injection Cangene Corporation (real clinical drug) | est un(e) (attribut) | VarIg varicella immunoglobulin unspecified | false | Inferred relationship | Some | ||
| VariZIG 125 international units powder and diluent for solution for injection Cangene Corporation (real clinical drug) | a pour principe actif (attribut) | Varicella immunoglobulin | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Historical name codes for passive immunizing agents reference set (foundation metadata concept)
FHIR